Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 279.10K | -1.90M | -784.50K | -784.50K | -323.10K |
| Total Depreciation and Amortization | 14.20K | 13.70K | 12.50K | 12.50K | 12.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.20M | 39.40K | 187.30K | 187.30K | 48.30K |
| Change in Net Operating Assets | 732.60K | 1.26M | 185.70K | 185.70K | -168.10K |
| Cash from Operations | -1.18M | -588.60K | -399.00K | -399.00K | -430.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.40K | -89.80K | -15.90K | -15.90K | -7.80K |
| Cash from Investing | -31.40K | -89.80K | -15.90K | -15.90K | -7.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.18M | 594.60K | 1.57M | 1.57M | 522.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.18M | 594.60K | 1.57M | 1.57M | 522.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.97M | -83.80K | 1.16M | 1.16M | 83.80K |